Beta Bionics Statistics

Total Valuation

Beta Bionics has a market cap or net worth of $749.53 million. The enterprise value is $556.92 million.

Market Cap	749.53M
Enterprise Value	556.92M

Important Dates

The next estimated earnings date is Tuesday, July 28, 2026, after market close.

Earnings Date	Jul 28, 2026
Ex-Dividend Date	n/a

Share Statistics

Beta Bionics has 44.56 million shares outstanding. The number of shares has increased by 250.60% in one year.

Current Share Class	44.56M
Shares Outstanding	44.56M
Shares Change (YoY)	+250.60%
Shares Change (QoQ)	+0.55%
Owned by Insiders (%)	5.52%
Owned by Institutions (%)	84.24%
Float	25.34M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	6.80
Forward PS	5.19
PB Ratio	2.76
P/TBV Ratio	2.76
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	5.05
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 10.69, with a Debt / Equity ratio of 0.03.

Current Ratio	10.69
Quick Ratio	9.39
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -22.71% and return on invested capital (ROIC) is -16.14%.

Return on Equity (ROE)	-22.71%
Return on Assets (ROA)	-15.04%
Return on Invested Capital (ROIC)	-16.14%
Return on Capital Employed (ROCE)	-27.49%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	$260,610
Profits Per Employee	-$157,066
Employee Count	423
Asset Turnover	0.34
Inventory Turnover	2.39

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +13.88% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+13.88%
50-Day Moving Average	12.03
200-Day Moving Average	18.30
Relative Strength Index (RSI)	74.27
Average Volume (20 Days)	1,103,439

Short Selling Information

The latest short interest is 5.20 million, so 11.67% of the outstanding shares have been sold short.

Short Interest	5.20M
Short Previous Month	5.69M
Short % of Shares Out	11.67%
Short % of Float	20.52%
Short Ratio (days to cover)	7.52

Income Statement

In the last 12 months, Beta Bionics had revenue of $110.24 million and -$66.44 million in losses. Loss per share was -$1.51.

Revenue	110.24M
Gross Profit	63.00M
Operating Income	-77.31M
Pretax Income	-66.44M
Net Income	-66.44M
EBITDA	-75.46M
EBIT	-77.31M
Loss Per Share	-$1.51

Full Income Statement

Balance Sheet

The company has $199.52 million in cash and $6.91 million in debt, giving a net cash position of $192.61 million or $4.32 per share.

Cash & Cash Equivalents	199.52M
Total Debt	6.91M
Net Cash	192.61M
Net Cash Per Share	$4.32
Equity (Book Value)	271.25M
Book Value Per Share	6.09
Working Capital	224.80M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$54.78 million and capital expenditures -$6.34 million, giving a free cash flow of -$61.12 million.

Operating Cash Flow	-54.78M
Capital Expenditures	-6.34M
Depreciation & Amortization	1.86M
Net Borrowing	n/a
Free Cash Flow	-61.12M
FCF Per Share	-$1.37

Full Cash Flow Statement

Margins

Gross margin is 57.15%, with operating and profit margins of -70.13% and -60.27%.

Gross Margin	57.15%
Operating Margin	-70.13%
Pretax Margin	-60.27%
Profit Margin	-60.27%
EBITDA Margin	-68.45%
EBIT Margin	-70.13%
FCF Margin	n/a

Dividends & Yields

Beta Bionics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-250.60%
Shareholder Yield	-250.60%
Earnings Yield	-8.86%
FCF Yield	-8.15%

Analyst Forecast

The average price target for Beta Bionics is $19.18, which is 14.03% higher than the current price. The consensus rating is "Buy".

Price Target	$19.18
Price Target Difference	14.03%
Analyst Consensus	Buy
Analyst Count	11
Revenue Growth Forecast (3Y)	35.98%
EPS Growth Forecast (3Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Beta Bionics has an Altman Z-Score of 13.15 and a Piotroski F-Score of 2.

Altman Z-Score	13.15
Piotroski F-Score	2